Head-to-head comparison of plasma biomarker assays across platforms for amyloid pathology in a multicenter cohort.
Science bulletin · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansFemaleBiomarkerstau ProteinsAmyloid beta-PeptidesMaleAgedAlzheimer DiseaseImmunoassayCognitive DysfunctionPositron-Emission TomographyMiddle AgedCohort StudiesDementiaPeptide FragmentsAlzheimer diseaseBlood-based biomarkersDiagnostic accuracyPhosphorylated tau 217
Come citare questo studio
Xinyi Lv, Kaiyuan Shen, Qianhua Zhao, Guoping Peng, Huayan Liu, Feng Gao, Xiaodong Pan, Wei Chen, Peilin Lu, Haining Zhang, Shuting Zhang, Mengya Xing, Qidong Chen, Yue Wang, Zhaozhao Cheng, Yiming Wang, Shilin Zeng, Fang Xie, Yuesong Pan, Yong Shen, Xiaochun Chen, Jiong Shi. (2026). Head-to-head comparison of plasma biomarker assays across platforms for amyloid pathology in a multicenter cohort.. Science bulletin. DOI: 10.1016/j.scib.2026.08.018
Consulta la pubblicazione originale ↗